Kartik Bomb, Paige J LeValley, Ian Woodward, Samantha E Cassel, Bryan P Sutherland, Arnab Bhattacharjee, Zaining Yun, Jonathan Steen, Emily Kurdzo, Jacob McCoskey, David Burris, Kara Levine, Christina Carbrello, Abraham M Lenhoff, Catherine A Fromen, April M Kloxin
Adoptive T-cell therapies (ATCTs) are increasingly important for the treatment of cancer, where patient immune cells are engineered to target and eradicate diseased cells. The biomanufacturing of ATCTs involves a series of time-intensive, lab-scale steps, including isolation, activation, genetic modification, and expansion of a patient's T-cells prior to achieving a final product. Innovative modular technologies are needed to produce cell therapies at improved scale and enhanced efficacy. In this work, well-defined, bioinspired soft materials were integrated within flow-based membrane devices for improving the activation and transduction of T cells...
March 24, 2023: Advanced Materials Technologies